JAMA Clinical Reviews
Worldwide, heterozygous familial hypercholesterolemia (FH) affects approximately 1 in 250 to 350 individuals. Author James Stein, MD, of the University of Wisconsin School of Medicine and Public Health joins JAMA Deputy Editor Karen Lasser, MD, MPH, to discuss the epidemiology, diagnosis, and treatment of both homozygous and heterozygous FH. Related Content: * Familial Hypercholesterolemia [https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2026.8822?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]
493 afleveringen
Reacties
0Wees de eerste die een reactie plaatst
Meld je nu aan en word lid van de JAMA Clinical Reviews community!